β-Cell mass dynamics and islet cell plasticity in human type 2 diabetes

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1462-1472

  Hanley, Stephen C ^a   Austin, Emily ^a   Assouline Thomas, Béatrice ^a   Kapeluto, Jordanna ^a   Blaichman, Jason ^a   Moosavi, Mandana ^a   Petropavlovskaia, Maria ^a   Rosenberg, Lawrence ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NEUROGENIN 3; NOTCH RECEPTOR; TRANSCRIPTION FACTOR PDX 1;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; CADAVER DONOR; CELL DEDIFFERENTIATION; CELL DIVISION; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEAN BODY WEIGHT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PLASTICITY; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; APOPTOSIS; CELL COUNT; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PANCREAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77950290798     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1277     Document Type: Article

References (66)

1. Kahn SE 2003 The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
2. Rhodes CJ 2005 Type 2 diabetes - a matter of β-cell life and death? Science 307:380-384
3. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A 2001 β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 50 (Suppl 1):S154-S159
4. Weir GC, Bonner-Weir S 2004 Five stages of evolving β-cell dys-function during progression to diabetes. Diabetes 53(Suppl 3):S16-S21
5. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P 2007 A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
6. Karam JH 1992 Type II diabetes and syndrome X. Pathogenesis and glycemic management. Endocrinol Metab Clin North Am 21:329-350
7. Yki-Järvinen H 1995 Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38:1378-1388
8. Ogilvie RF 1933 The islands of Langerhans in 19 cases of obesity. J Pathol Bacteriol 37:473-481
9. Klöppel G, Löhr M, Habich K, Oberholzer M, Heitz PU 1985 Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110-125
10. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
11. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC 2008 Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32-42
12. Maedler K, Donath MY 2004 β-Cells in type 2 diabetes: a loss of function and mass. Horm Res 62(Suppl 3):67-73
13. Gumbiner B, Van Cauter E, Beltz WF, Ditzler TM, Griver K, Polonsky KS, Henry RR 1996 Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab 81:2061-2068
14. Gerich JE 1998 The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19:491-503
15. Del Prato S, Marchetti P, Bonadonna RC 2002 Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 51(Suppl 1):S109-S116
16. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC 2006 Relationship between β-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717-718
17. Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca F, Del Prato S 2004 Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89:5535-5541
18. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, Velidedeoglu E, Desai NM, Koeberlein B, Wolf B, Barker CF, Naji A, Matschinsky FM, Markmann JF 2004 Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53:624-632
19. Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U, Del Prato S, Rabuazzo AM, Purrello F, Marchetti P 2005 Functional and morphological alterations of mitochondria in pancreatic β cells from type 2 diabetic patients. Diabetologia 48:282-289
20. Ostenson CG, Gaisano H, Sheu L, Tibell A, Bartfai T 2006 Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 55:435-440
21. Yuan S, Rosenberg L, Paraskevas S, Agapitos D, Duguid WP 1996 Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61:67-75
22. Jamal AM, Lipsett M, Sladek R, Laganière S, Hanley S, Rosenberg L 2005 Morphogenetic plasticity of adult human pancreatic islets of Langerhans. Cell Death Differ 12:702-712
23. Gao R, Ustinov J, Pulkkinen MA, Lundin K, Korsgren O, Otonkoski T 2003 Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 52:2007-2015
24. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM 2004 Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 306:2261-2264
25. Gao R, Ustinov J, Korsgren O, Otonkoski T 2005 In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 48:2296-2304
26. Lechner A, Nolan AL, Blacken RA, Habener JF 2005 Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun 327:581-588
27. Ouziel-Yahalom L, Zalzman M, Anker-Kitai L, Knoller S, Bar Y, Glandt M, Herold K, Efrat S 2006 Expansion and redifferentiation of adult human pancreatic islet cells. Biochem Biophys Res Commun 341:291-298
28. Hanley SC, Pilotte A, Massie B, Rosenberg L 2008 Cell origins of adult human islet in vitro dedifferentiation. Lab Invest 88:761-772
29. Russ HA, Bar Y, Ravassard P, Efrat S 2008 In vitro proliferation of cells derived from adult human β-cells revealed by cell-lineage tracing. Diabetes 57:1575-1583
30. Bar Y, Russ HA, Knoller S, Ouziel-Yahalom L, Efrat S 2008 Hes1 is involved in adaptation of adult human β cells to proliferation in vitro. Diabetes 57:2413-2420
31. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H 1999 Notch signalling controls pancreatic cell differentiation. Nature 400:877-881
32. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD 2000 Control of endodermal endocrine development by Hes-1. Nat Genet 24:36-44
33. Fujikura J, Hosoda K, Iwakura H, Tomita T, Noguchi M, Masuzaki H, Tanigaki K, Yabe D, Honjo T, Nakao K 2006 Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas. Cell Metab 3:59-65
34. Greenwood AL, Li S, Jones K, Melton DA 2007 Notch signaling reveals developmental plasticity of Pax4(+) pancreatic endocrine progenitors and shunts them to a duct fate. Mech Dev 124:97-107
35. Hald J, Hjorth JP, German MS, Madsen OD, Serup P, Jensen J 2003 Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev Biol 260:426-437
36. Sommer L, Ma Q, Anderson DJ 1996 Neurogenins, a novel family of atonal-related bH LH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS. Mol Cell Neurosci 8:221-241
37. Lardelli M, Williams R, Mitsiadis T, Lendahl U 1996 Expression of the Notch 3 intracellular domain in mouse central nervous system progenitor cells is lethal and leads to disturbed neural tube development. Mech Dev 59:177-190
38. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW 1988 Automated method for isolation of human pancreatic islets. Diabetes 37:413-420
39. Githens 3rd S, Holmquist DR, Whelan JF, Ruby JR 1980 Ducts of the rat pancreas in a agarose matrix culture. In Vitro 16:797-808
40. Wang R, Li J, Rosenberg L 2001 Factors mediating the transdifferentiation of islets of Langerhans to duct epithelial-like structures. J Endocrinol 171:309-318
41. Lipsett MA, Austin EB, Castellarin ML, Lemay J, Rosenberg L 2006 Evidence for the homeostatic regulation of induced β cell mass expansion. Diabetologia 49:2910-2919
42. Hanley SC, Paraskevas S, Rosenberg L 2008 Donor and isolation variables predicting human islet isolation success. Transplantation 85:950-955
43. Matsumoto S, Zhang G, Qualley S, Clever J, Tombrello Y, Strong DM, Reems JA 2004 Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 36:1034-1036
44. Finegood DT, Scaglia L, Bonner-Weir S 1995 Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256
45. Bouwens L, Pipeleers DG 1998 Extra-insular β cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629-633
46. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC 1988 Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151-159
47. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S 2003 Selective β-cell loss and β-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308
48. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR 2005 Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349
49. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, Miller CP, Weir GC, Habener JF, Bonner-Weir S 1999 The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48:507-513
50. Jarriault S, Le Bail O, Hirsinger E, Pourquié O, Logeat F, Strong CF, Brou C, Seidah NG, Israel A 1998 Δ-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 18:7423-7431
51. Darville MI, Eizirik DL 2006 Notch signaling: a mediator of β-cell de-differentiation in diabetes? Biochem Biophys Res Commun 339:1063-1068
52. Cardozo AK, Kruhøffer M, Leeman R, Orntoft T, Eizirik DL 2001 Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920
53. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD 2003 Notch mediates TGF α-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3:565-576
54. Kutlu B, Cardozo AK, Darville MI, Kruhøffer M, Magnusson N, Ørntoft T, Eizirik DL 2003 Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719
55. Chen CD, Oh SY, Hinman JD, Abraham CR 2006 Visualization of APP dimerization and APP-Notch2 heterodimerization in living cells using bimolecular fluorescence complementation. J Neurochem 97:30-43
56. Hart A, Papadopoulou S, Edlund H 2003 Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Dev Dyn 228:185-193
57. Prentki M, Corkey BE 1996 Are the β-cell signaling molecules malonyl-Co A and cystolic long-chain acyl-Co A implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283
58. Prentki M, Joly E, El-Assaad W, Roduit R 2002 Malonyl-Co A signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 51(Suppl 3):S405-S413
59. Matveyenko AV, Butler PC 2008 Relationship between β-cell mass and diabetes onset. Diabetes Obes Metab 10(Suppl 4):23-31
60. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S, Weir GC 2003 Critical reduction in β-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 278:2997-3005
61. Seeberger KL, Eshpeter A, Rajotte RV, Korbutt GS 2009 Epithelial cells within the human pancreas do not coexpress mesenchymal antigens: epithelial-mesenchymal transition is an artifact of cell culture. Lab Invest 89:110-121
62. Xu X, D'Hoker J, Stangé G, Bonné S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G, Heimberg H 2008 β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132:197-207
63. Dor Y, Brown J, Martinez OI, Melton DA 2004 Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46
64. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA 2007 Growth and regeneration of adult β cells does not involve specialized progenitors. Dev Cell 12:817-826
65. Butler AE, Janson J, Soeller WC, Butler PC 2003 Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314
66. Hanley S, Rosenberg L 2007 Transforming growth factor-β is a critical regulator of adult human islet plasticity. Mol Endocrinol 21:1467-1477